Answers are grounded in this paper and cite their sources.
Genome-editing CRISPR-Cas systems, using Cas9 and Cas12a endonucleases, have improved our ability to precisely edit genomes and control gene expression. We summarize here the knowledge gained from using CRISPR-Cas9 and CRISPR-Cas12a in fungal research. Also discussed are strategies developed for limiting the occurrences of off-target mutations caused by CRISPR-Cas genome editing.
No takes yet. Share an insight, caveat, or question.
Ouedraogo et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: